Since October 2014, all federal Cook IVC filter lawsuits have been transferred to the U.S. District Court for the Southern District of Indiana. Plaintiffs claim to have suffered serious side effects after being implanted with these filters, which are designed to help prevent blood clots…
All federal Xarelto lawsuits, which were consolidated into the Eastern District of Louisiana in December 2014, involve patients who took the drugs and then suffered serious side effects. According to the latest case list from the court, there are now nearly 1,700 cases pending, with…
Over 1,900 Xarelto lawsuits are currently pending in state and federal courts, with plaintiffs claiming that the anticoagulant caused serious injuries, including gastrointestinal bleeding, blood clots, stroke, and heart attack. Within just a couple years of being on the market, Xarelto (rivaroxaban)
A recent NBC News report raised serious questions about the safety of Bard IVC filters. These filters are implanted in the inferior vena cava (IVC)—the vein taking blood from the lower legs back to the heart—in patients who are at risk of pulmonary embolism (PE),…
On September 1, 2015, plaintiffs filed another Zofran lawsuit in the Central District of California. Though there has been no Zofran MDL established yet, Zofran manufacturer GlaxoSmithKline (GSK) has filed a motion requesting that all federally filed Zofran lawsuits be brought together in one court…
Researchers have reported on a serious potential side effect with temporary inferior vena cava (IVC) filters. The small, cage-like devices are inserted into the vena cava vein, which takes deoxygenated blood from the lower legs back to the heart. It is this vein that can…
Express Scripts, the largest U.S. pharmacy benefit manager, has excluded Onglyza (saxagliptin), a type 2 diabetes medication, and Kombiglyze XR ata gliptin plus metformin, from insurance coverage. That means that patients using this drug may have to pay the full retail price for it. Why…
An FDA advisory panel has recommended that Onglyza (saxagliptin), a type 2 diabetes medication, should have its warning label updated to indicate that it could increase risk of heart failure. Onglyza belongs to a class of drugs known as “dipeptidyl peptidase-4 (DDP-4) inhibitors.” Also called…
The number of Zofran lawsuits filed across the country continues to increase. Moms who took Zofran for morning sickness during pregnancy and then gave birth to babies with birth defects now seek to hold manufacturer GlaxoSmithKline (GSK) liable for medical expenses. Considering the growing litigatio
On August 17, 2015, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Bard IVC filter lawsuits into one court in the District of Arizona. They assigned District Judge David G. Campbell to oversee the coordinated proceedings. A total of 22 cases were…
According to a study recently published in the Journal of the American Medical Association, the use of inferior vena cava (IVC) filters among patients with severe pulmonary embolism (PE) provides no additional health benefits over using anticoagulant medications alone—and may cause additional seriou
An FDA advisory panel has recommended that Onglyza (saxagliptin), a type 2 diabetes medication, should have its warning label updated to indicate that it could increase risk of heart failure. Onglyza belongs to a class of drugs known as “dipeptidyl peptidase-4 (DDP-4) inhibitors.” Also called…
